As mGluR5 is widely distributed throughout the basal ganglia, selective antagonism of this receptor by MPEP/MTEP or negative allosteric modulators (NAMs) has been shown to promote neuroprotection in PD [80]. The gene discussed is GRM5; the disease is Parkinson disease.